Drug profile · INN
epoprostenol
VELETRI
epoprostenol (VELETRI) is a prostanoid ip receptor agonist. Associated with Janssen-Cilag Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — epoprostenol
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.81
Quick answer
epoprostenol (VELETRI) is a prostanoid ip receptor agonist. Associated with Janssen-Cilag Pty Ltd.
Key facts
INN epoprostenol
Brand VELETRI
Mechanism Prostanoid IP receptor agonist
Originator Janssen-Cilag Pty Ltd
Mechanism of action
Prostanoid IP receptor agonist
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is epoprostenol?
epoprostenol (VELETRI) is a prostanoid ip receptor agonist. Associated with Janssen-Cilag Pty Ltd.
What is the brand name for epoprostenol?
VELETRI is a marketed brand name for epoprostenol. Check FDA Drugs@FDA for the current US label holder and prescribing information.